Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) (2022)

First Author: Smith T
Attributed to:  New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06533-0

PubMed Identifier: 35869526

Publication URI: http://europepmc.org/abstract/MED/35869526

Type: Journal Article/Review

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215